Citations (94)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Miguel Glatstein, Dennis Scolnik & Yedidia Bentur. (2012) Octreotide for the treatment of sulfonylurea poisoning. Clinical Toxicology 50:9, pages 795-804.
Read now
Read now
Paul Glare, Jeanna Miller, Tanya Nikolova & Roma Tickoo. (2011) Treating nausea and vomiting in palliative care: a review. Clinical Interventions in Aging 6, pages 243-259.
Read now
Read now
Jan Bornschein, Ignat Drozdov & Peter Malfertheiner. (2009) Octreotide LAR: safety and tolerability issues. Expert Opinion on Drug Safety 8:6, pages 755-768.
Read now
Read now
M. Bildozola. (2000) Efficacy of Octreotide and Sclerotherapy in the Treatment of Acute Variceal Bleeding in Cirrhotic Patients: A Prospective, Multicentric, and Randomized Clinical Trial. Scandinavian Journal of Gastroenterology 35:4, pages 419-425.
Read now
Read now
K. Witt & N. Thorsgaard Pedersen. (1989) The Long-Acting Somatostatin Analogue SMS 201-995 Causes Malabsorption. Scandinavian Journal of Gastroenterology 24:10, pages 1248-1252.
Read now
Read now
Articles from other publishers (89)
Anwar Khedr, Esraa Elaraby Mahmoud, Noura Attallah, Mikael Mir, Sydney Boike, Ibtisam Rauf, Abbas B Jama, Hisham Mushtaq, Salim Surani & Syed A Khan. (2022) Role of octreotide in small bowel bleeding. World Journal of Clinical Cases 10:26, pages 9192-9206.
Crossref
Crossref
Rishabha Malviya, Swati Verma & Sonali Sundram. (2022) Advancement and Strategies for the Development of Peptide-drug Conjugates:
Pharmacokinetic Modulation, Role and Clinical Evidence against
Cancer Management. Current Cancer Drug Targets 22:4, pages 286-311.
Crossref
Crossref
Akshay KothariDrDrKiran ShahDrDr. (2021) ROLE OF OCTREOTIDE IN MANAGEMENT OF SULPHONYLUREA - INDUCED REFRACTORY HYPOGLYCEMIA : A CASE REPORT. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 3-4.
Crossref
Crossref
Staffan Berg, Julius Krause, Anders Björkbom, Katrin Walter, Said Harun, Andreas Granfeldt, David Janzén, Sandro Filipe Nunes, Malin Antonsson, Natalie Van Zuydam, Stanko Skrtic, Andreas Hugerth, Werner Weitschies, Nigel Davies, Bertil Abrahamsson & Christel A.S. Bergström. (2021) In Vitro and In Vivo Evaluation of 3D Printed Capsules with Pressure Triggered Release Mechanism for Oral Peptide Delivery. Journal of Pharmaceutical Sciences 110:1, pages 228-238.
Crossref
Crossref
Max Sauter, Philipp Uhl, Jürgen Burhenne & Walter E. Haefeli. (2020) Post-extraction disulfide bond cleavage for MS/MS quantification of collision-induced dissociation-resistant cystine-cyclized peptides and its application to the ultra-sensitive UPLC-MS/MS bioanalysis of octreotide in plasma. Analytica Chimica Acta 1114, pages 42-49.
Crossref
Crossref
Lili Cui, Zecheng Yang, Ming Li, Zhonglin Wei, Qiang Fei, Yanfu Huan & Hongmei Li. (2019) Structural characterization of octreotide impurities by on-line electrochemistry-tandem mass spectrometry. International Journal of Mass Spectrometry 435, pages 18-25.
Crossref
Crossref
Tara L. Molina, Jill C. Krisl, Kevin R. Donahue & Sara Varnado. (2018) Gastrointestinal Bleeding in Left Ventricular Assist Device: Octreotide and Other Treatment Modalities. ASAIO Journal 64:4, pages 433-439.
Crossref
Crossref
Fredrik Tiberg, John Roberts, Camilla Cervin, Markus Johnsson, Severine Sarp, Anadya Prakash Tripathi & Margareta Linden. (2015) Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF‐1 suppression to octreotide LAR in healthy volunteers. British Journal of Clinical Pharmacology 80:3, pages 460-472.
Crossref
Crossref
Li Di. (2014) Strategic Approaches to Optimizing Peptide ADME Properties. The AAPS Journal 17:1, pages 134-143.
Crossref
Crossref
Jun Kamishikiryou, Saori Nishiya, Hitomi Murakami, Noriko Senoo, Hiromi Tsutsui, Michiko Yamasaki, Kiyoshi Hattori, Kenji Furuya & Narumi Sugihara. (2014) Remaining Level of Octreotide Administered by Mixed Injection into ELNEOPA No 1. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 40:1, pages 54-61.
Crossref
Crossref
Philip Stevens, Sorrel Burden, Raymond Delicata, Gordon Carlson & Simon Lal. (2013) Somatostatin analogues for treatment of enterocutaneous fistula. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Amir H. Ghassemi, Mies J. van Steenbergen, Arjan Barendregt, Herre Talsma, Robbert J. Kok, Cornelus F. van Nostrum, Daan J. A. Crommelin & Wim E. Hennink. (2011) Controlled Release of Octreotide and Assessment of Peptide Acylation from Poly(D,L-lactide-co-hydroxymethyl glycolide) Compared to PLGA Microspheres. Pharmaceutical Research 29:1, pages 110-120.
Crossref
Crossref
Waleed Alhazzani, Lay Lay Win, Colin W Howden & Grigorios I Leontiadis. (2011) Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleeding. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Philip Stevens, Rhiannon E. Foulkes, Jake S. Hartford-Beynon & Raymond J. Delicata. (2011) Systematic review and meta-analysis of the role of somatostatin and its analogues in the treatment of enterocutaneous fistula. European Journal of Gastroenterology & Hepatology 23:10, pages 912-922.
Crossref
Crossref
Yuko Iwase & Yoshie Maitani. (2010) Octreotide-Targeted Liposomes Loaded with CPT-11 Enhanced Cytotoxicity for the Treatment of Medullary Thyroid Carcinoma. Molecular Pharmaceutics 8:2, pages 330-337.
Crossref
Crossref
Annamaria Colao, Renata S. Auriemma, Gaetano Lombardi & Rosario Pivonello. (2011) Resistance to Somatostatin Analogs in Acromegaly. Endocrine Reviews 32:2, pages 247-271.
Crossref
Crossref
Paul A. Glare & Tanya Nikolova. 2011. Supportive Oncology. Supportive Oncology
258
273
.
Vinita Pai, Kyle Porter & Mark Ranalli. (2011) Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease. Pediatric Blood & Cancer 56:1, pages 45-49.
Crossref
Crossref
Patrick P. Dougherty & Wendy Klein-Schwartz. (2010) Octreotide’s Role in the Management of Sulfonylurea-Induced Hypoglycemia. Journal of Medical Toxicology 6:2, pages 199-206.
Crossref
Crossref
D A J Lloyd, S M Gabe & A C J Windsor. (2006) Nutrition and management of enterocutaneous fistula. British Journal of Surgery 93:9, pages 1045-1055.
Crossref
Crossref
Javier P. Gisbert. (2006) Tratamiento farmacológico de la hemorragia digestiva por úlcera péptica. Medicina Clínica 127:2, pages 66-75.
Crossref
Crossref
Andy Nydegger, Richard T L Couper & Mark R Oliver. (2006) Childhood pancreatitis. Journal of Gastroenterology and Hepatology 21:3, pages 499-509.
Crossref
Crossref
Hirofumi KISHIKAWA, Yosuke OKADA, Akiko HIROSE, Takahisa TANIKAWA, Kazuko KANDA & Yoshiya TANAKA. (2006) Successful Treatment of Insulinoma by a Single Daily Dose of Octreotide in Two Elderly Female Patients. Endocrine Journal 53:1, pages 79-85.
Crossref
Crossref
J J Sancho, J di Costanzo, P Nubiola, A Larrad, A Beguiristain, F Roqueta, G Franch, A Oliva, J M Gubern & A Sitges-Serra. (1995) Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. British Journal of Surgery 82:5, pages 638-641.
Crossref
Crossref
Beatrice Astruc, Peter Marbach, Hakim Bouterfa, Caroline Denot, Mitra Safari, Alessandra Vitaliti & Michael Sheppard. (2005) Long-Acting Octreotide and Prolonged-Release Lanreotide Formulations Have Different Pharmacokinetic Profiles. The Journal of Clinical Pharmacology 45:7, pages 836-844.
Crossref
Crossref
S.I. Helle, W. Mietlowski, J.P. Guastalla, I. Szakolczai, E. Bajetta, H. Sommer, E. Baltali, T. Pinter, M. Csepreghy, L. Ottestad, C. Boni, C. Bryce, J.G.M. Klijn & P.E. Lønning. (2005) Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy. European Journal of Cancer 41:5, pages 694-701.
Crossref
Crossref
Aurélie Plessier. (2004) Comment traiter une hémorragie digestive aiguë par rupture de varices oesophagiennes. Gastroentérologie Clinique et Biologique 28, pages 15-20.
Crossref
Crossref
M Falconi, R Salvia, G Mascetta, W Mantovani, N Sartori, G Butturini, C Bassi & P Pederzoli. (2004) Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review. Digestive and Liver Disease 36, pages S121-S127.
Crossref
Crossref
Edoardo Camenzind, Willem H. Bakker, Ambroos Reijs, Alberto Righetti, Ingeborg M. van Geijlswijk, Eric Boersma, David Foley, Eric P. Krenning, Jos RTC. Roelandt & Patrick W. Serruys. (2004) Site-Specific Intracoronary Delivery of Octreotide in Humans: A Pharmacokinetic Study to Determine Dose-Efficacy in Restenosis Prevention. Journal of Cardiovascular Pharmacology 43:1, pages 133-139.
Crossref
Crossref
Christina S. Chu & Stephen C. Rubin. 2004. Gynecologic Cancer. Gynecologic Cancer
727
741
.
Paolo Carcoforo, Giorgio Soliani, Umberto Maestroni, A Donini, Daniel Inderbitzin, Thomas T Hui, Alan Lefor, Itzhak Avital & Giuseppe Navarra. (2003) Octreotide in the Treatment of Lymphorrhea After Axillary Node Dissection: A Prospective Randomized Controlled Trial. Journal of the American College of Surgeons 196:3, pages 365-369.
Crossref
Crossref
Sylvie Froidevaux & Alex N. Eberle. (2004) Somatostatin analogs and radiopeptides in cancer therapy. Peptide Science 66:3, pages 161-183.
Crossref
Crossref
Georg H Stoll, Fritz Nimmerfall, Murat Acemoglu, David Bodmer, Siegfried Bantle, Irene Müller, Andreas Mahl, Maryelle Kolopp & Kjell Tullberg. (2001) Poly(ethylene carbonate)s, part II11Part I: see Ref. [15].: degradation mechanisms and parenteral delivery of bioactive agents. Journal of Controlled Release 76:3, pages 209-225.
Crossref
Crossref
Joseph D. Pianka & John Affronti. (2001) Management principles of gastrointestinal bleeding. Primary Care: Clinics in Office Practice 28:3, pages 557-575.
Crossref
Crossref
Àngels Escorsell, Juan Carlos Bandi, Victòria Andreu, Eduardo Moitinho, Joan Carles Garcí-Pagán, Jaume Bosch & Joan Rodés. (2001) Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 120:1, pages 161-169.
Crossref
Crossref
Peter J. Gilbar. (2016) The role of octreotide in symptom management in oncology and palliative care. Journal of Oncology Pharmacy Practice 6:3, pages 81-91.
Crossref
Crossref
Hironosuke Sakamoto. (2006) Cardiovascular Effects of Octreotide, a Long‐Acting Somatostatin Analog. Cardiovascular Drug Reviews 17:4, pages 358-373.
Crossref
Crossref
Ludwig, Terai, Brüning & Stange. (2001) Long‐term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo‐controlled echo–doppler study. Alimentary Pharmacology & Therapeutics 13:8, pages 1119-1129.
Crossref
Crossref
E. Comets, F. Mentré, F. Nimmerfall, R. Kawai, I. Mueller, P. Marbach & J. Vonderscher. (1999) Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR. Journal of Controlled Release 59:2, pages 197-205.
Crossref
Crossref
Giuseppe Scalera & Giorgio Tarozzi. (1998) Somatostatin administration alters taste preferences in the rat. Peptides 19:9, pages 1565-1572.
Crossref
Crossref
G. Stöcklin & H. J. Wester. 1998. Positron Emission Tomography: A Critical Assessment of Recent Trends. Positron Emission Tomography: A Critical Assessment of Recent Trends
57
90
.
R CHAUDHRY, BALWINDER SINGH & P SUBHAS. (1997) OCTREOTIDE IN GASTROENTEROLOGY. Medical Journal Armed Forces India 53:4, pages 293-294.
Crossref
Crossref
Andreas Zielke, Christian Hasse, Christian Bruns, Helmut Sitter & Matthias Rothmund. (1997) Octreotide: Effective treatment for hyperparathyroidism? A prospective, randomized, controlled clinical trial. Surgery 121:6, pages 606-610.
Crossref
Crossref
Lone Harild Ottesen, Allan Flyvbjerg, Preben Jakobsen & Flemming Bendtsen. (1997) The pharmacokinetics of octreotide in cirrhosis and in healthy man. Journal of Hepatology 26:5, pages 1018-1025.
Crossref
Crossref
Pierre Martineau, Jill A. Shwed & Ronald Denis. (1996) Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?. The American Journal of Surgery 172:4, pages 386-395.
Crossref
Crossref
F. Fiedler, G. Jauernig, V. Keim, A. Richter & H. J. Bender. (1996) Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure. Intensive Care Medicine 22:9, pages 909-915.
Crossref
Crossref
G. Zironi, C. Rossi, S. Siringo, C. Galaverni, S. Gaiani, F. Piscaglia & L. Bolondi. (2008) Short‐ and long‐term hemodynamic response to octreotide in portal hypertensive patients: a double‐blind, controlled study. Liver 16:4, pages 225-234.
Crossref
Crossref
Florence Bétoin, Charles Advenier, Véronique Fardin, George Wilcox, Jeannine Lavarenne & Alain Eschalier. (1995) In vitro and in vivo evidence for a tachykinin NK1 receptor antagonist effect of vapreotide, an analgesic cyclic analog of somatostatin. European Journal of Pharmacology 279:2-3, pages 241-249.
Crossref
Crossref
K. W. Simpson, R. L. Stepien, C. M. Elwood, A. Boswood & C. R. Vaillant. (2008) Evaluation of the long‐acting somatostatin analogue Octreotide in the management of insulinoma in three dogs. Journal of Small Animal Practice 36:4, pages 161-165.
Crossref
Crossref
M. Bayraktar, A. Usman & Z. Koray. (1994) Effect of the new somatostatin analogue SMS 201-995 on exogenously used insulin. The Clinical Investigator 72:9, pages 669-672.
Crossref
Crossref
Andrea I. Sargent, Carroll C. Overton, Richard J. Kuwik, Jorge R. Varcelotti & Scott A. Deppe. (2012) Octreotide‐Induced Hyperkalemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 14:4, pages 497-501.
Crossref
Crossref
Fricker, Valerie Dubost, Dietmar Schwab, Christian Bruns & Christoph Thiele. (1994) Heterogeneity in hepatic transport of somatostatin analog octapeptides. Hepatology 20:1, pages 191-200.
Crossref
Crossref
Roberto Valcavl & Michele Zinl. (2010) Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone‐releasing hormone in normal subjects. Clinical Endocrinology 40:3, pages 379-382.
Crossref
Crossref
B. ANNIBALE, G. DELLE FAVE, C. AZZONI, V. CORLETO, G. CAMBONI, G. D'AMBRA, F. P. PILATO & C. BORDI. (2007) Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger‐Ellison syndrome and antral G‐cell hyperfunction. Alimentary Pharmacology & Therapeutics 8:1, pages 95-104.
Crossref
Crossref
Xian-Feng Zhu, Alan G. Harris, Mei Fang Yang, Yi-Fan Shi, Qian Zhou, Jing-Ying Xu & Jin-Xi Zhang. (1994) Effect of octreotide on dynamic excretion of bile in Chinese acromegalic patients assessed by [99mTc]EHIDA hepatobiliary scan. Digestive Diseases and Sciences 39:2, pages 284-288.
Crossref
Crossref
Andrew J. Krentz, Patrick J. Boyle, Linda M. Macdonald & David S. Schade. (1994) Octreotide: A long-acting inhibitor of endogenous hormone secretion for human metabolic investigations. Metabolism 43:1, pages 24-31.
Crossref
Crossref
Sebastiano Mercadante, Elio Spoldi, Augusto Caraceni, Salvatore Maddaloni & Maria Teresa Simonetti. (2016) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliative Medicine 7:4, pages 295-299.
Crossref
Crossref
Grimaldi Charles, Jacques Darcourt, Alan G. Harris, Evelyne Lebot, Fran�oise Lapalus & Jean Delmont. (1993) Cholescintigraphic study of effect of somatostatin analog, octreotide, on bile secretion and gallbladder emptying in normal subjects. Digestive Diseases and Sciences 38:9, pages 1718-1721.
Crossref
Crossref
Rudolf Arnold, Christian Neuhaus, Ralph Benning, Wolf B. Schwerk, Michael E. Trautmann, Klaus Joseph & Christian Bruns. (1993) Somatostatin analog Sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors. World Journal of Surgery 17:4, pages 511-519.
Crossref
Crossref
Christine Silvain, Stéphane Carpentier, Denis Sautereau, Bella Czernichow, Jean-michel Métreau, Eric Fort, Pierre Ingrand, Jean Boyer, Bernard Pillegand, Michel Doffël, Daniel Dhumeaux & Michel Beauchan. (1993) Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial. Hepatology 18:1, pages 61-65.
Crossref
Crossref
William L. Hasler, Hani C. Soudan & Chung Owyang. (1993) A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention. Gastroenterology 104:5, pages 1390-1397.
Crossref
Crossref
T. P. Kemmer, M. Büchler & P. Malfertheiner. 1993. Standards in Pancreatic Surgery. Standards in Pancreatic Surgery
691
702
.
Sebastiano Mercadante & Salvatore Maddaloni. (1992) Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. Journal of Pain and Symptom Management 7:8, pages 496-498.
Crossref
Crossref
Samuel Klein, Farook Jahoor, Hidefumi Baba, Courtney M. TownsendJrJr, Mary Shepherd & Robert R. Wolfe. (1992) In vivo assessment of the metabolic alterations in glucagonoma syndrome. Metabolism 41:11, pages 1171-1175.
Crossref
Crossref
Paul N. Maton & R.T. Jensen. (1992) USE OF GUT PEPTIDE RECEPTOR AGONISTS AND ANTAGONISTS IN GASTROINTESTINAL DISEASES. Gastroenterology Clinics of North America 21:3, pages 551-566.
Crossref
Crossref
K.E. Gyr & R. Meier. (1992) Pharmacodynamic effects of Sandostatin® in the gastrointestinal tract. Metabolism 41:9, pages 17-21.
Crossref
Crossref
P. Marbach, U. Briner, M. Lemaire, A. Schweitzer & T. Terasaki. (1992) From somatostatin to Sandostatin®: Pharmacodynamics and pharmacokinetics. Metabolism 41:9, pages 7-10.
Crossref
Crossref
D. Bodmer, T. Kissel & E. Traechslin. (1992) Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. Journal of Controlled Release 21:1-3, pages 129-137.
Crossref
Crossref
Roger D. Hurst & Irvin M. Modlin. (1991) The therapeutic role of octreotide in the management of surgical disorders. The American Journal of Surgery 162:5, pages 499-507.
Crossref
Crossref
A. K. BURROUGHS & P. A. McCORMICK. (2007) Somatostatin and octreotide in gastroenterology. Alimentary Pharmacology & Therapeutics 5:4, pages 331-341.
Crossref
Crossref
Nathalie Rivard, Difu Guan, C.M. Turkelson, Denis Petitclerc, Travis E. Solomon & Jean Morisset. (1991) Negative control by Sandostatin on pancreatic and duodenal growth: a possible implication of insulin-like growth factor I. Regulatory Peptides 34:1, pages 13-23.
Crossref
Crossref
L. S. Miller, J. D. Gardner, J. Doppman & R. T. Jensen. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease
349
400
.
Y. F. SHI, A. G. HARRIS, X. F. ZHU & J. Y. DENG. (1990) CLINICAL AND BIOCHEMICAL EFFECTS OF INCREMENTAL DOSES OF THE LONG-ACTING SOMATOSTATIN ANALOGUE SMS 201-995 IN TEN ACROMEGALIC PATIENTS. Clinical Endocrinology 32:6, pages 695-705.
Crossref
Crossref
R. ARNOLD. (2008) Therapeutic strategies in the management of endocrine GEP tumours. European Journal of Clinical Investigation 20:1, pages 82-90.
Crossref
Crossref
Norman A. Mazer. (1990) Pharmacokinetic and pharmacodynamic aspects of polypeptide delivery. Journal of Controlled Release 11:1-3, pages 343-356.
Crossref
Crossref
W. E. KARNES, V. MAXWELL, B. SYTNIK, P. CHEW & J. H. WALSH. (2007) Prolonged inhibition of meal‐stimulated acid secretion and gastrin release following single subcutaneous administration of octreotide (SMS 201–995) in man. Alimentary Pharmacology & Therapeutics 3:6, pages 527-538.
Crossref
Crossref
Paul N. Maton. (1989) The Use of the Long-Acting Somatostatin Analogue, Octreotide Acetate, in Patients with Islet Cell Tumors. Gastroenterology Clinics of North America 18:4, pages 897-922.
Crossref
Crossref
R.T. Borchardt, N.A. Mazer, J.H. Rytting, E. Shek, E. Ziv, E. Touitou & W.I. Higuchi. (1989) The delivery of peptides. Journal of Pharmaceutical Sciences 78:11, pages 883-892.
Crossref
Crossref
John Christiansen, Rudolf Ottenjann & Frank von Arx. (1989) Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding. Gastroenterology 97:3, pages 568-574.
Crossref
Crossref
J. M. D. NIGHTINGALE, E. R. WALKER, W. R. BURNHAM, M. J. G. FARTHING & J. E. LENNARD-JONES. (2007) Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Alimentary Pharmacology & Therapeutics 3:4, pages 367-373.
Crossref
Crossref
L. S. ERIKSSON & J. WAHREN. (2008) Intravenous and subcutaneous administration of a long‐acting somatostatin analogue: effects on glucose metabolism and splanchnic haemodynamics in healthy subjects. European Journal of Clinical Investigation 19:2, pages 213-219.
Crossref
Crossref
C. A. RODRIGUES, J. E. LENNARD‐JONES, D. G. THOMPSON & M. J. G. FARTHING. (2007) The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short‐bowel syndrome. Alimentary Pharmacology & Therapeutics 3:2, pages 159-169.
Crossref
Crossref
Richard N. Fedorak & Sherie L. Allen. (1989) Effect of somatostatin analog (SMS 201-995) onin vivo intestinal fluid transport in rats. Digestive Diseases and Sciences 34:4, pages 567-572.
Crossref
Crossref
Walter Londong, Michael Angerer, Klaus Kutz, Ruediger Landgraf & Vera Londong. (1989) Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration. Gastroenterology 96:3, pages 713-722.
Crossref
Crossref
Paul N. Maton, Jerry D. Gardner & Robert T. Jensen. (1989) Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Digestive Diseases and Sciences 34:S3, pages S28-S39.
Crossref
Crossref
Walter Londong, Michael Angerer, Klaus Kutz, Ruediger Landgraf & Vera Londong. (1989) Diminishing Efficacy of Octreotide (SMS 201-995) on Gastric Functions of Healthy Subjects During One-Week Administration. Gastroenterology 96:2, pages 713-722.
Crossref
Crossref
Jack M. Rosenberg. (1988) Octreotide: A Synthetic Analog of Somatostatin. Drug Intelligence & Clinical Pharmacy 22:10, pages 748-754.
Crossref
Crossref
H. S. FUESSL, J. M. BURRIN, G. WILLIAMS, T. E. ADRIAN & S. R. BLOOM. (2007) The effect of a long‐acting somatostatin analogue (SMS 201–995) on intermediary metabolism and gut hormones after a test meal in normal subjects. Alimentary Pharmacology & Therapeutics 1:4, pages 321-330.
Crossref
Crossref
R. G. LONG. (2007) Review: long‐acting somatostatin analogues. Alimentary Pharmacology & Therapeutics 1:3, pages 191-200.
Crossref
Crossref